The performance of different asset classes used to diverge. When interest rates were soaring, stocks slumped. Some didn’t care because those high interest rates were
Read More
In The Rear View Mirror: With the June jobs report in the books, two things are now abundantly clear. First, the U.S. economy is fragile
Read More
By the strictest of definitions, Synergy Pharmaceuticals (NASDAQ: SGYP) currently resides at the upper range of the micro-cap universe with a market capitalization just south
Read More
If you’re a so-called “average guy,” you probably have a favorite pair of blue jeans. Perhaps you’ve owned that pair for years upon years. Those
Read More In The Rear View Mirror: With the benefit of a Europe-induced rally, U.S. equities surged on the final trading day of June. European policymakers finally
Read More
As hard as it may be to believe, big bank stocks have performed fairly well this year. The Select Sector SPDR-Financial (NYSE: XLF), the largest
Read More In The Rear View Mirror: A Facebook reminder for most investors and what an epic amount of headline risk does to the market. U.S. stocks
Read More
Investing in the micro-cap health care sector is 180 degrees removed from your grandfather’s idea of health care stocks. Everyone knows what kind of stocks
Read More In The Rear View Mirror: The weekly gains were small, but they were enough to help U.S. equities to their second consecutive weekly finish in
Read More
It’s simple economics really. Natural gas prices are trading near decade lows. Oil prices are trading at multi-year highs. Yes, it would be better for
Read More
